Stis Prevention

2

Review clinical trials related to Stis Prevention. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Combatting HIV Or Other STIs Early (CHOOSE)

The overarching goal of this project is to optimize the PrEP Choice integrated mHealth package and assess the efficacy and cost of PrEP Choice on PrEP initiation and adherence among young people. It is hypothesized that PrEP Choice will improve HIV PrEP uptake and adherence among young people and will be cost-effective to deliver to young people in the United States (U.S.). This study will also assess the uptake, adherence, and acceptability of DoxyPEP among young people.

Participants needed: 200
Trial details
Phase: Phase 2Age: 13-24Biological sex: MaleType: InterventionalSponsor: WestatUpdated: Jul 13, 2026Locations: 6
Eligibility criteria

Age 13-24 years, inclusive; [+11]

Female; [+6]

Status: Not yet recruiting

Combatting HIV Or Other STIs Early (CHOOSE)

The overarching goal of this project is to optimize the PrEP Choice integrated mHealth package and assess the efficacy and cost of PrEP Choice on PrEP initiation and adherence among young people. It is hypothesized that PrEP Choice will improve HIV PrEP uptake and adherence among young people and will be cost-effective to deliver to young people in the United States (U.S.). This study will also assess the uptake, adherence, and acceptability of DoxyPEP among young people.

Participants needed: 200
Trial details
Phase: Phase 2Age: 13-24Biological sex: MaleType: InterventionalSponsor: WestatUpdated: May 22, 2026Locations: 6
Eligibility criteria

Age 13-24 years, inclusive; [+11]

Female; [+6]